The purpose of this study is to determine whether there is a relationship between serial B-natriuretic peptide (BNP) and implantable device measured intrathoracic impedance in symptomatic and asymptomatic heart failure patients over a 1-year period. Furthermore, this study will establish whether implantable device measured intrathoracic impedance trends with the distance walked on a six-minute hall walk (6MHW), an exercise-based acute measure that has also been associated with heart failure clinical status.
This is a prospective non-randomized longitudinal study. One hundred subjects will participate in 6 monthly and 3 bi-monthly serial assessments of plasma-based BNP, implantable device measured intrathoracic impedance, and clinical evaluation of heart failure status. Each patient will be enrolled in the study for a period of 12 months.
Study Type
OBSERVATIONAL
Enrollment
100
Glendale Memorial Hospital and Health Center
Glendale, California, United States
RECRUITINGSouthern New Jersey Cardiac Specialists
Voorhees Township, New Jersey, United States
RECRUITINGSt. Francis Hospital
Roslyn, New York, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Carolinas Healthcare System/The Sanger Clinic
Charlotte, North Carolina, United States
RECRUITINGMid State Cardiology Associates
Nashville, Tennessee, United States
RECRUITINGMedical College of Wisconsin /Froedtert Hospital
Milwaukee, Wisconsin, United States
NOT_YET_RECRUITING